Skip to main content
TipRanks
Go Ultimate75% OFF

Jeffrey Abbey Insider Profile

4 Followers

Jeffrey Abbey, former CEO, Director at Argos Therapeutics, holds 25.45K shares in Argos Therapeutics (Ticker: ARGSQ).

Jeffrey Abbey's Trading History

ARGSQ
Argos Therapeutics
Apr 25, 2018―Uninformative Sell―$1.35K
ARGSQ
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Apr 25, 2018Uninformative Sell$0.0067,887$0.00―
Mar 30, 2018Uninformative Buy$0.0067,887$0.00―
Jan 12, 2018Uninformative Sell$20.00K124,987$0.16―
Jan 05, 2018Uninformative Sell$18.35K114,702$0.16―
Jan 05, 2018Uninformative Sell$18.35K114,702$0.16―

You May Also Like

Jeffrey Abbey insider profile FAQ

What is the percentage of profitable transactions made by Jeffrey Abbey?
The percentage of profitable transactions made by Jeffrey Abbey is 67%.
What is the average return per transaction made by Jeffrey Abbey?
The average return per transaction made by Jeffrey Abbey is 45.70%.
What stocks does Jeffrey Abbey hold?
Jeffrey Abbey holds: ARGSQ stocks.
What was Jeffrey Abbey's most profitable transaction?
Jeffrey Abbey’s most profitable transaction was an Informative Buy of ARGSQ stock on December 17, 2015. The return on the trade was 152.70%.
What is Jeffrey Abbey's role in Argos Therapeutics?
Jeffrey Abbey's role in Argos Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.